Based on NIH | Are heart palpitations a symptom of endometrial cancer, and what key items should be included in a patient checklist when assessing this complaint?

Heart palpitations are not a typical symptom of endometrial (uterine) cancer itself. The most common symptoms of endometrial cancer are abnormal vaginal bleeding (especially after menopause), pelvic pain or pressure, trouble or pain with urination, pain with intercourse, and sometimes unexplained weight loss in later stages. ^{[1] [2]} Palpitations can occur in people with endometrial cancer, but they are more often explained by other causes such as anemia from heavy bleeding, thyroid problems, medication or treatment effects, stress or anxiety, pain, infection, dehydration, or underlying heart rhythm issues. ^{[3] [4]} Palpitations in those receiving chemotherapy or immunotherapy may signal treatment‑related toxicities (for example, thyroid inflammation or cardiotoxicity) and warrant prompt clinical review. ^{[5] [6]}

Why palpitations happen in this setting

• Anemia from heavy uterine bleeding can trigger a faster or forceful heartbeat and even chest discomfort, because the heart works harder to carry oxygen; addressing the blood loss usually improves symptoms. ^{[7] [3]}
• Thyroid dysfunction, including immune‑therapy–related thyroiditis, may cause a “racing” or irregular heartbeat when the thyroid is overactive, and a slow heartbeat when underactive; programs often monitor thyroid function during treatment. ^{[5] [8]}
• Some cancer treatments can affect the heart directly; anthracyclines (such as doxorubicin) have recognized delayed cardiotoxicity that can present with chest symptoms, shortness of breath, swelling, or an abnormal heartbeat. ^{[6] [9]}
• Infections, dehydration, fever, stimulants (caffeine, nicotine), and hormonal changes (including menopause) are additional common triggers of palpitations in the general population and may coexist in those with cancer. ^{[10] [11]}
• Overall, palpitations are frequent in people living with cancer and should be assessed similarly to the general population, with extra attention to cancer‑ and treatment‑specific risks. ^{[12] [13]}

Red‑flag features that need urgent care

• Chest pain, shortness of breath, fainting, severe dizziness, or a new very fast or very slow heartbeat should prompt immediate evaluation, as these can indicate a dangerous arrhythmia, cardiotoxicity, pulmonary issues, or severe anemia. ^{[14] [15]}
• During active treatment, rapid or irregular heartbeat accompanied by fever, worsening cough, or breathing difficulty should be reported urgently, as this may reflect lung inflammation or infection. ^{[16] [14]}
• New palpitations with swelling of the ankles, new shortness of breath, or reduced exercise tolerance may reflect heart dysfunction and should be assessed promptly. ^{[6] [9]}

---

Patient checklist for assessing palpitations

Use this structured checklist to guide discussion with your clinician and to help prioritize testing.

1) Symptom description

• What do you feel: racing, pounding, skipped beats, fluttering, or irregular pulse; how fast; and whether it starts and stops suddenly or gradually. ^[4]
• Timing and triggers: at rest or with activity, after caffeine or alcohol, with fever, during stress/anxiety, or around hot flashes/menopause symptoms. ^{[10] [11]}
• Duration and frequency: seconds, minutes, hours; once a week vs. multiple times per day; any pattern. ^[12]
• Associated symptoms: chest pain/pressure, shortness of breath, lightheadedness, near‑fainting, fainting, fatigue, new ankle swelling. ^{[15] [6]}

2) Bleeding and anemia screen

• Any abnormal uterine or vaginal bleeding (between periods, after sex, or after menopause), heavy or prolonged periods, clots, or new spotting after menopause. ^{[1] [3]}
• Symptoms of anemia: fatigue, pallor, shortness of breath on exertion, or chest discomfort; ask whether recent blood counts were checked. ^{[7] [14]}

3) Treatment status and medications

• Current or recent cancer treatments (chemotherapy, immunotherapy, or targeted agents) and the cycle timing relative to palpitations. ^{[14] [5]}
• Specific agents of concern: anthracyclines (e.g., doxorubicin) for delayed cardiotoxicity; checkpoint inhibitors (e.g., durvalumab, dostarlimab) for thyroid or cardiac immune effects. ^{[6] [8]}
• Other medicines and supplements: decongestants, asthma medicines, thyroid pills, stimulants, or high caffeine intake that may provoke palpitations. ^{[10] [4]}

4) Thyroid and endocrine symptoms

• Signs of overactive thyroid: heat intolerance, sweating, weight loss, anxiety, tremor, diarrhea, difficulty sleeping, and fast heartbeat. ^{[5] [8]}
• Signs of underactive thyroid: cold intolerance, weight gain, fatigue, dry skin, constipation, slow heartbeat, and hair loss. ^{[8] [17]}

5) Infection, dehydration, and lifestyle factors

• Fever, cough, or other signs of infection; recent vomiting/diarrhea; fluid intake and dehydration risks. ^{[14] [16]}
• Caffeine, nicotine, alcohol, energy drinks, recreational stimulants; intense exercise or poor sleep. ^{[10] [4]}

6) Past heart history and risk

• Prior heart disease, high blood pressure, valvular problems, known arrhythmias, or prior abnormal ECGs. ^{[9] [12]}
• Family history of early heart disease or sudden death; current blood pressure and electrolytes if available. ^{[10] [12]}

7) Objective data to bring (if possible)

• Home heart rate during episodes versus baseline; any smartwatch ECG tracings; recent complete blood count, thyroid tests, electrolytes; and a current medication list. ^{[12] [5]}

---

How clinicians typically evaluate

• History and physical exam with vital signs and a 12‑lead ECG are standard first steps. This helps determine if there is a dangerous rhythm or conduction problem. ^[12]
• Targeted labs often include complete blood count (to look for anemia), thyroid function tests, and electrolytes; additional tests are guided by symptoms and treatment exposures. ^{[3] [5]}
• If episodes are intermittent, ambulatory monitoring (Holter or patch) may be used; echocardiography is considered if cardiotoxic therapy exposure or heart failure signs are present. ^{[6] [12]}
• For those on therapies linked to thyroid or cardiac effects, programs commonly schedule regular monitoring and advise reporting rapid or irregular heartbeat promptly. ^{[5] [6]}

---

Take‑home points

• Palpitations are not a hallmark symptom of endometrial cancer; abnormal vaginal bleeding is the most common early sign, and any postmenopausal bleeding warrants evaluation. ^{[1] [18]}
• In people with or being evaluated for endometrial cancer, palpitations are more often due to anemia from heavy bleeding, thyroid dysfunction (sometimes treatment‑related), medication/stimulant effects, or common non‑cancer causes. However, serious heart or lung problems must be ruled out when red flags are present. ^{[7] [5]}
• During and after certain treatments, new palpitations may signal thyroid problems or cardiotoxicity; timely reporting allows early testing and management. ^{[8] [6]}

If you’d like, I can turn the above checklist into a printable one‑page sheet you can take to your appointment.